Cargando…
Intratympanic injection of dexamethasone for management of labyrinthitis associated with COVID-19 disease resistant cases
OBJECTIVE: To evaluate the efficacy of mixed oral prednisolone and intratympanic dexamethasone (ITID) injection in labyrinthitis, due to COVID 19. METHODS: Seventy-five post-COVID-19 labyrinthitis patients were included. Those patients were treated with systemic oral prednisolone for two weeks and I...
Autores principales: | Ismaiel, Wael F., Abdelazim, Mohamed H., Wahba, Ashraf A., Alsobky, Mahmoud E., Ibrahim, Ahmed Abdalrhman, Ghanem, Soliman A., Rabaan, Ali A., Ismail, Elshahat I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384350/ https://www.ncbi.nlm.nih.gov/pubmed/35989722 http://dx.doi.org/10.1016/j.amsu.2022.104429 |
Ejemplares similares
-
Outcome of the endoscopic repair of frontal sinus cerebrospinal fluid leak
por: Ismaiel, Wael F., et al.
Publicado: (2021) -
The predictive value of nasolacrimal sac biopsy in endoscopic dacryocystorhinostomy
por: Eldsoky, Ibrahim, et al.
Publicado: (2021) -
Injectable Poloxamer Hydrogel Formulations for Intratympanic Delivery of Dexamethasone
por: Le, Thi Phuc, et al.
Publicado: (2023) -
The impact of COVID-19 outbreak on the incidence of acute invasive fungal rhinosinusitis
por: Ismaiel, Wael F., et al.
Publicado: (2021) -
Intratympanic dexamethasone injection for sudden sensorineural hearing loss in pregnancy
por: Lyu, Yan-Lu, et al.
Publicado: (2020)